Niagen Bioscience (NAGE) EBIAT (2016 - 2025)
Historic EBIAT for Niagen Bioscience (NAGE) over the last 17 years, with Q3 2025 value amounting to $4.6 million.
- Niagen Bioscience's EBIAT rose 14377.0% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.5 million, marking a year-over-year increase of 128154.88%. This contributed to the annual value of $8.6 million for FY2024, which is 27415.96% up from last year.
- As of Q3 2025, Niagen Bioscience's EBIAT stood at $4.6 million, which was up 14377.0% from $3.6 million recorded in Q2 2025.
- Niagen Bioscience's EBIAT's 5-year high stood at $7.2 million during Q4 2024, with a 5-year trough of -$8.9 million in Q3 2021.
- In the last 5 years, Niagen Bioscience's EBIAT had a median value of -$985000.0 in 2022 and averaged -$1.4 million.
- Its EBIAT has fluctuated over the past 5 years, first plummeted by 11010.68% in 2021, then soared by 2416000.0% in 2025.
- Niagen Bioscience's EBIAT (Quarter) stood at -$5.3 million in 2021, then skyrocketed by 73.37% to -$1.4 million in 2022, then skyrocketed by 108.04% to $114000.0 in 2023, then soared by 6241.23% to $7.2 million in 2024, then tumbled by 36.67% to $4.6 million in 2025.
- Its last three reported values are $4.6 million in Q3 2025, $3.6 million for Q2 2025, and $5.1 million during Q1 2025.